Creso Pharma (ASX:CPH)

Creso Pharma (ASX:CPH)

Creso Pharma (ASX:CPH) was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere.

Founded by a team of highly-experienced pharmaceutical executives, Creso Pharma set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.

As a global operation since inception, Creso Pharma’s experienced leadership and geographical agility has enabled tactical expansion in a diverse range of markets:

  • First to import medicinal cannabis into Australia
  • First launches of innovative products into Switzerland for humans and animals
  • Launch of anibidiol®: the first hemp CBD based complementary feed in animal health in partnership with Virbac Switzerland (Global Animal Health company)
  • Launch of cannaQIX®: the first CBD nutraceutical in human health in partnership with Doetsch Grether AG Switzerland (Swiss OTC Pharma)
  • Formally entered the Canadian market by acquiring Mernova, a Nova Scotia based Medical Cannabis growing operation
  • Pioneered new opportunities for cannabis and hemp derived ingredients in the lifestyle space, specifically chocolates and alcoholic and non-alcoholic beverages

Board and Management

Dr Halperin Wernli
Group CEO, Co–Founder and Executive Director

Dr. Halperin Wernli is a senior pharma executive with over 25 years of strategic and operational leadership in global drug and product development in the pharmaceutical and biomedical industries. She held worldwide executive leadership positions in R&D and in strategic marketing within global pharmaceutical companies in Switzerland and in the US.

Boaz Wachtel 
Chairman and Co-Founder

Boaz Wachtel is a leading Medical cannabis expert, co-founder and former managing director of Phytotech Medical (MMJ.ASX), Australia’s first publicly traded medical cannabis company. He initiated and helped implement the National Medical Cannabis Program in Israel.

Wachtel is a certified Clinical research manager and holds an MA in management and marketing from the University of Maryland.

Adam Blumenthal 
Non- Executive Director & Co – Founder

Adam Blumenthal has 10 years experience in investment banking and corporate finance. He has deep exposure to Australian and International markets, having provided capital raising and financing solutions to an extensive number of listed and unlisted companies.

He has successfully brought t several medical cannabis companies to market, spanning Israel, Canada, Switzerland and Australia.

John Griese
Chief Operating Officer

John Griese is an expert in cannabis and food manufacturing and supply chain.

Griese has 30 years experience in executive operations roles with Pepsi and Nestle and more recently developed Cannabis experience as COO of Bloom Farms a large branded manufacturer and distributor in the California regulated market.

Creso Pharma (ASX:CPH)